Beijing Scitop Bio-tech Co (300858.SZ) Stock Price
Beijing Scitop Bio-tech Co Price
Over the last 10 years Beijing Scitop Bio-tech Co grew revenue by 7.0% annually, reaching 365.92 M CNY. Earnings per share have grown at 10.4% per year over the last 10 years. For Beijing Scitop Bio-tech Co, the net margin of 25.8% is down versus 30.0% a few years ago. At today's price the dividend yield works out to roughly 1.02%. The payout ratio is around 43% of earnings. The consensus 12-month price target for Beijing Scitop Bio-tech Co is 18.02 CNY, about 22.6% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.
Beijing Scitop Bio-tech Co stock price
Beijing Scitop Bio-tech Co business model & stock analysis
Frequently asked questions about Beijing Scitop Bio-tech Co
Analysts currently set an average price target of 18.02 CNY for the Beijing Scitop Bio-tech Co stock (median: 18.02 CNY), implying +22.6 % versus the latest price. The consensus is based on 6 analyst ratings.
5 analysts currently rate the Beijing Scitop Bio-tech Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Beijing Scitop Bio-tech Co to generate revenue of 533.67 M CNY and earnings per share of 0.57 CNY.
Converted at the current exchange rate, the Beijing Scitop Bio-tech Co share trades at 1.96 EUR (14.70 CNY).
The Beijing Scitop Bio-tech Co share (300858.SZ) is listed on 1 stock exchanges, including: Shenzhen (300858.SZ).
The expected revenue of Beijing Scitop Bio-tech Co is 533.67 M CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Beijing Scitop Bio-tech Co is 155.47 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Beijing Scitop Bio-tech Co is currently 25.86. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Beijing Scitop Bio-tech Co stock.
The price-to-sales ratio (P/S) of Beijing Scitop Bio-tech Co is currently 7.53. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Beijing Scitop Bio-tech Co stock.
The Eulerpool Quality Score for Beijing Scitop Bio-tech Co is 5/10.
The ISIN of Beijing Scitop Bio-tech Co is CNE100004181. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Beijing Scitop Bio-tech Co is 300858.SZ. The ticker symbol is used to trade Beijing Scitop Bio-tech Co shares on the stock exchange.
Beijing Scitop Bio-tech Co stock
Beijing Scitop Bio-tech Co Peer Group
Beijing Scitop Bio-tech Co Ticker
Beijing Scitop Bio-tech Co FIGI
All fundamentals and in-depth analysis of Beijing Scitop Bio-tech Co
Our stock analysis for Beijing Scitop Bio-tech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beijing Scitop Bio-tech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.